Inventor · disambiguated record
Jerry M. Buysse
Also filed as: BUYSSE JERRY · BUYSSE JERRY M · LIU MINGJUN
28 granted patents·20 pending applications·266 citations·filing 1996–2024
97Inventor score
Top patents by PatentIndex Score
48 records- 0198US9993500B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2017·Granted Jun 12, 2018·15 cites·32 claims
- 0297US9925214B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2015·Granted Mar 27, 2018·13 cites·53 claims
- 0396US10369169B1Proton-binding polymers for oral administrationTRICIDA INC·Filed 2019·Granted Aug 6, 2019·8 cites·21 claims
- 0496US9205107B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2014·Granted Dec 8, 2015·22 cites·30 claims
- 0594US11406661B2HCl-binding compositions for and methods of treating acid-base disordersTRICIDA INC·Filed 2017·Granted Aug 9, 2022·4 cites·15 claims
- 0694US11197887B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2019·Granted Dec 14, 2021·4 cites·11 claims
- 0794US10363268B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2018·Granted Jul 30, 2019·8 cites·5 claims
- 0893US7556799B2Ion binding polymers and uses thereofRELYPSA INC·Filed 2005·Granted Jul 7, 2009·13 cites·19 claims
- 0992US10391118B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2018·Granted Aug 27, 2019·8 cites·46 claims
- 1091US11311571B2Proton-binding polymers for oral administrationTRICIDA INC·Filed 2015·Granted Apr 26, 2022·3 cites·11 claims
- 1191US8475780B2Ion binding polymers and uses thereofCHARMOT DOMINIQUE·Filed 2011·Granted Jul 2, 2013·8 cites·18 claims
- 1291US8216560B2Ion binding polymers and uses thereofCHARMOT DOMINIQUE·Filed 2008·Granted Jul 10, 2012·8 cites·22 claims
- 1391US7666898B2Multivalent indole compounds and use thereof as phospholipase-A2 inhibitorsILYPSA INC·Filed 2006·Granted Feb 23, 2010·34 cites·15 claims
- 1491US7488495B2Ion binding polymers and uses thereofRELYPSA INC·Filed 2004·Granted Feb 10, 2009·31 cites·20 claims
- 1590US7589238B2Treatment of hyperphosphatemia using crosslinked small molecule amine polymersILYPSA INC·Filed 2006·Granted Sep 15, 2009·14 cites·66 claims
- 1689US7776319B2Methods and compositions for treatment of ion imbalancesRELYPSA INC·Filed 2005·Granted Aug 17, 2010·8 cites·15 claims
- 1788US11992501B2Compositions for and methods of treating acid-base disordersRENOSIS INC·Filed 2021·Granted May 28, 2024·1 cites·53 claims
- 1888US8889115B2Ion binding polymers and uses thereofRELYPSA INC·Filed 2012·Granted Nov 18, 2014·5 cites·31 claims
- 1987US7854924B2Methods and compositions for treatment of ion imbalancesRELYPSA INC·Filed 2004·Granted Dec 21, 2010·18 cites·39 claims
- 2084US2023405043A1Proton-binding polymers for oral administrationRENOSIS INC·Filed 2023·Application pending·0 cites
- 2183US11266684B2Compositions for and method of treating acid-base disordersTRICIDA INC·Filed 2018·Granted Mar 8, 2022·4 cites·7 claims
- 2283US7608674B2Pharmaceutical compositions comprising cross-linked small molecule amine polymersILYPSA INC·Filed 2004·Granted Oct 27, 2009·16 cites·49 claims
- 2383US2022096534A1Proton-binding polymers for oral administrationTRICIDA INC·Filed 2021·Application pending·0 cites
- 2481US11738041B2Proton-binding polymers for oral administrationRENOSIS INC·Filed 2022·Granted Aug 29, 2023·0 cites·10 claims
- 2575US2025009785A1Hcl-binding compositions for and methods of treating acid-base disordersRENOSIS INC·Filed 2022·Application pending·0 cites
- 2674US2020085856A1Ion binding polymers and uses thereofVIFOR INT LTD·Filed 2019·Application pending·0 cites
- 2773US2025222021A1Method of treating acid-base disordersRENOSIS INC·Filed 2024·Application pending·0 cites
- 2873US2025025494A1Compositions for and method of treating acid-base disordersRENOSIS INC·Filed 2024·Application pending·0 cites
- 2971US2021205351A1Compositions for treating acid-base disordersTRICIDA INC·Filed 2021·Application pending·0 cites
- 3070US11986490B2Compositions for and method of treating acid-base disordersRENOSIS INC·Filed 2022·Granted May 21, 2024·0 cites·21 claims
- 3169US2014286891A1Ion binding polymers and uses thereofRELYPSA INC·Filed 2014·Application pending·0 cites
- 3267US10485821B2Ion binding polymers and uses thereofVIFOR INT LTD·Filed 2016·Granted Nov 26, 2019·0 cites·24 claims
- 3366US7718746B2Anion-binding polymers and uses thereofILYPSA INC·Filed 2009·Granted May 18, 2010·0 cites·20 claims
- 3460US10058567B2Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammalRELYPSA INC·Filed 2016·Granted Aug 28, 2018·0 cites·14 claims
- 3558USH1892HHigh volume nutrient based yeast two-hybrid assay for the identification of specific protein:protein interacting inhibitorsUPJOHN CO·Filed 1996·Granted Oct 3, 2000·15 cites·1 claims
- 3658US2021187011A1Method of treating acid-base disordersTRICIDA INC·Filed 2018·Application pending·0 cites
- 3755US2006078534A1Toxin binding compositionsCHARMOT DOMINIQUE·Filed 2004·Application pending·0 cites
- 3855US2005244367A1Phospholipase inhibitors localized in the gastrointestinal lumenILYPSA INC·Filed 2004·Application pending·0 cites
- 3954US2008021049A1Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related CompoundsBUYSSE JERRY M·Filed 2005·Application pending·0 cites
- 4054US2007292385A1Phospholipase Inhibitors Localized in the Gastrointestinal LumenCHARMOT DOMINIQUE·Filed 2005·Application pending·0 cites
- 4151US2008051447A1Treatment Of Hypercholesterolemia, Hypertriglyceridemia And Cardiovascular-Related Conditions Using Phospholipase-A2 InhibitorsCHARMOT DOMINIQUE·Filed 2005·Application pending·0 cites
- 4251US2005288255A1Modulation of lysophosphatidylcholine and treatment of diet-induced conditionsHUI DAVID·Filed 2005·Application pending·0 cites
- 4347US5962249ASized-based marker identification technologyMICROCIDE PHARMACEUTICALS INC·Filed 1996·Granted Oct 5, 1999·6 cites·34 claims
- 4442US2006099169A1Toxin binding compositionsILYPSA INC·Filed 2005·Application pending·0 cites
- 4537US2009318492A1Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4637US2009306171A1Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4737US2009239896A1Azaindole compounds and use thereof as phospholipase-a2 inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
- 4836US2007135383A1Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitorsCHANG HAN-TING·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jerry M. Buysse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →